Irreversibility of symptoms with biotin therapy in an adult with profound biotinidase deficiency

Patrick Ferreira, Alicia Chan, Barry Wolf*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

7 Scopus citations

Abstract

We report a 36-year-old woman who exhibited progressive optic atrophy at 13 years old, then stroke-like episodes and spastic diplegia in her 20s. Biotinidase deficiency was not readily considered in the differential diagnosis, and the definitive diagnosis was not made until pathological variants of the biotinidase gene (BTD) were found by exome sequencing. Profound biotinidase deficiency was confirmed by enzyme analysis. Unfortunately, her symptoms did not resolve or improve with biotin treatment. Biotin therapy is essential for all individuals with profound biotinidase deficiency and for preventing further damage in those who already exhibit irreversible neurological damage. Newborn screening for the disorder would have avoided years of clinical symptoms that now appear to be irreversible with biotin treatment.

Original languageEnglish (US)
Title of host publicationJIMD Reports
PublisherSpringer
Pages117-120
Number of pages4
DOIs
StatePublished - Jan 1 2017

Publication series

NameJIMD Reports
Volume36
ISSN (Print)2192-8304
ISSN (Electronic)2192-8312

Keywords

  • Adult
  • Biotin
  • Biotinidase
  • Biotinidase deficiency
  • Myelopathy
  • Optic atrophy
  • Spastic diplegia

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)

Fingerprint Dive into the research topics of 'Irreversibility of symptoms with biotin therapy in an adult with profound biotinidase deficiency'. Together they form a unique fingerprint.

Cite this